Imu Biosciences

Provider of immune discovery platform for precision medicines

placeLondon, England, United Kingdom calendar_todayFounded 2019 language imubiosciences.com

Social engagement

Social engagement: 7.5K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include Molten Ventures.

Investor typeCountShare
Venture capital3100%

Recent activity

24 Jun 2026
Partnership
Waters Corporation
Coming soon